PRESTIGE CONSUMER HEALTHCARE INC. Inventory
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) had Inventory of $190.22 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-08-06
- 2026-06-30: Inventory, Net $190.22M.
- 2026-03-31: Inventory, Net $159.13M.
- 2025-12-31: Inventory, Net $163.59M.
- 2025-09-30: Inventory, Net $159.00M.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2026-06-30 | $190.22M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $159.13M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $163.59M 10-Q · filed 2026-02-05 | |
| 2025-09-30 | $159.00M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $153.13M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $147.71M 10-K · filed 2026-05-14 | |
| 2024-12-31 | $151.52M 10-Q · filed 2025-02-06 | |
| 2024-09-30 | $156.22M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $152.04M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $138.72M 10-K · filed 2025-05-09 | |
| 2023-12-31 | $148.64M 10-Q · filed 2024-02-08 | |
| 2023-09-30 | $161.28M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $169.85M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $162.12M 10-K · filed 2024-05-15 | |
| 2022-12-31 | $158.52M 10-Q · filed 2023-02-02 | |
| 2022-09-30 | $140.50M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $133.77M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $120.34M 10-K · filed 2023-05-05 | |
| 2021-12-31 | $106.27M 10-Q · filed 2022-02-03 | |
| 2021-09-30 | $107.92M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $105.55M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $114.96M 10-K · filed 2022-05-06 | |
| 2020-12-31 | $117.01M 10-Q · filed 2021-02-04 | |
| 2020-09-30 | $114.03M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $116.81M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $116.03M 10-K · filed 2021-05-07 | |
| 2019-12-31 | $121.36M 10-Q · filed 2020-02-06 | |
| 2019-09-30 | $126.36M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $129.39M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $119.88M 10-K · filed 2020-05-08 | |
| 2018-12-31 | $120.37M 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $113.57M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $118.96M 10-Q · filed 2018-08-02 | |
| 2018-04-01 | $116.78M 10-Q · filed 2019-02-07 | |
| 2018-03-31 | $118.55M 10-K · filed 2019-05-13 | |
| 2017-12-31 | $114.89M 10-Q · filed 2018-02-01 | |
| 2017-09-30 | $119.48M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $118.71M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $115.61M 10-K · filed 2018-05-10 | |
| 2016-12-31 | $100.93M 10-Q · filed 2017-02-02 | |
| 2016-09-30 | $97.96M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $92.87M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $91.26M 10-K · filed 2017-05-17 | |
| 2015-12-31 | $80.67M 10-Q · filed 2016-02-04 | |
| 2015-09-30 | $77.14M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $74.08M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $74.00M 10-K · filed 2016-05-17 | |
| 2014-12-31 | $75.24M 10-Q · filed 2015-02-05 | |
| 2014-09-30 | $82.88M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $66.17M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $65.59M 10-K · filed 2015-05-14 | |
| 2013-12-31 | $64.80M 10-Q · filed 2014-02-07 | |
| 2013-09-30 | $61.94M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $66.92M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $60.20M 10-K · filed 2014-05-19 | |
| 2012-12-31 | $54.25M 10-Q · filed 2013-02-07 | |
| 2012-09-30 | $53.84M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $60.20M 10-Q · filed 2013-08-01 | $53.85M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $51.11M 10-K · filed 2013-05-17 | |
| 2011-12-31 | $43.58M 10-Q · filed 2012-02-09 | |
| 2011-09-30 | $46.41M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $43.72M 10-Q · filed 2011-08-05 | |
| 2011-03-31 | $39.75M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |